Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers
- 31 May 2011
- journal article
- research article
- Published by Elsevier BV in Reproductive Toxicology
- Vol. 31 (4), 540-545
- https://doi.org/10.1016/j.reprotox.2011.02.008
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Angiotensin II receptor antagonist treatment during pregnancyBirth Defects Research Part A: Clinical and Molecular Teratology, 2005
- Angiotensin II‐receptor‐antagonists: Further evidence of fetotoxicity but not teratogenicityBirth Defects Research Part A: Clinical and Molecular Teratology, 2003
- Placental passage of angiotensin-converting enzyme inhibitorsAmerican Journal of Obstetrics and Gynecology, 1996
- Comparison of the transplacental transfer of enalapril, captopril and losartan in sheepBritish Journal of Pharmacology, 1995
- Teratogen update: Angiotensin‐converting enzyme inhibitorsTeratology, 1994
- Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.Circulation, 1994
- Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: A prospective, placebo-controlled study in baboons (Papio hamadryas)American Journal of Obstetrics and Gynecology, 1994
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- ACE inhibitor fetopathy and hypocalvaria: The kidney–skull connectionTeratology, 1991
- POSSIBLE RISK WITH CAPTOPRIL IN PREGNANCY: SOME ANIMAL DATAThe Lancet, 1980